Inotiv, Inc. (NOTV)

NCM – Цена в реальном времени. Валюта: USD

0.25

-0.05 (-15.91%)

При закрытии: May 12, 2026, 4:00 PM EDT

0.24

-0.01 (-2.79%)

До открытия: May 13, 2026, 5:59 AM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Inotiv, Inc. (NOTV)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inotiv, Inc. (NOTV)

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Search stocks

Inotiv, Inc. (NOTV)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inotiv, Inc. (NOTV)

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities